GLP-2 Reduces Gut Permeability But Doesn't Prevent Type 1 Diabetes in NOD Mice
GLP-2 reduced intestinal permeability in NOD mice but did not prevent type 1 diabetes onset, separating gut barrier repair from autoimmune diabetes prevention — gut healing alone doesn't prevent autoimmunity.
Quick Facts
What This Study Found
GLP-2 reduced intestinal permeability in NOD mice but did not prevent type 1 diabetes onset, separating gut barrier repair from autoimmune diabetes prevention — gut healing alone doesn't prevent autoimmunity.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding GLP-2 reduced intestinal permeability in NOD mice but did not prevent type 1 diabetes onset, separating gut barrier repair from autoimmune diabetes pr
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2009.
- Original Title:
- Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.
- Published In:
- Endocrinology, 150(2), 592-9 (2009)
- Authors:
- Hadjiyanni, Irene, Li, Kunmin Karen, Drucker, Daniel J(11)
- Database ID:
- RPEP-01487
Evidence Hierarchy
Frequently Asked Questions
What was studied?
GLP-2 Reduces Gut Permeability But Doesn't Prevent Type 1 Diabetes in NOD Mice
What was found?
GLP-2 reduced intestinal permeability in NOD mice but did not prevent type 1 diabetes onset, separating gut barrier repair from autoimmune diabetes prevention — gut healing alone doesn't prevent autoimmunity.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01487APA
Hadjiyanni, Irene; Li, Kunmin Karen; Drucker, Daniel J. (2009). Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.. Endocrinology, 150(2), 592-9. https://doi.org/10.1210/en.2008-1228
MLA
Hadjiyanni, Irene, et al. "Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.." Endocrinology, 2009. https://doi.org/10.1210/en.2008-1228
RethinkPeptides
RethinkPeptides Research Database. "Glucagon-like peptide-2 reduces intestinal permeability but ..." RPEP-01487. Retrieved from https://rethinkpeptides.com/research/hadjiyanni-2009-glucagonlike-peptide2-reduces-intestinal
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.